EGFLAM-AS1

Across TCGA pan-cancer cohorts, EGFLAM-AS1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of EGFLAM-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where EGFLAM-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EGFLAM-AS1 is over-expressed in tumor.

HNSC, LUAD, and LUSC are the cancer types where EGFLAM-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EGFLAM-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	All	+0.094	.039	1	view →
LUAD	All	All	+0.061	.032	1	view →
LUSC	All	All	+0.039	.044	1	view →
KIRC	All	All	+0.014	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

EGFLAM-AS1–HNSC

Open the HNSC breakdown →